MDAX

Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

Retrieved on: 
Tuesday, November 7, 2023
MDAX, Frankfurt Stock Exchange, IND, Therapy, ISIN, EVO, Risk, Partnership, Hotel des Indes (The Hague), Dew point, IndiGo, AI, Sales, Pharmaceutical industry, Evotec

Under the collaboration, Evotec will facilitate the rapid development of Dewpoint’s oncology assets using Evotec’s fully integrated clinical-enabling INDiGO platform to de-risk and accelerate the path to clinical testing.

Key Points: 
  • Under the collaboration, Evotec will facilitate the rapid development of Dewpoint’s oncology assets using Evotec’s fully integrated clinical-enabling INDiGO platform to de-risk and accelerate the path to clinical testing.
  • Dr. Matthias Evers, Chief Business Officer of Evotec, commented, “We are excited to enter this strategic development partnership with Dewpoint.
  • By combining our complementary expertise, Evotec’s development platform will serve as the capital-efficient IND engine for this highly collaborative partnership.
  • We look forward to working closely together with their team to make Dewpoint’s groundbreaking innovations available to patients.”
    “Dewpoint’s strategic partnership with Evotec leverages the world-class speed of their development platform to accelerate our oncology assets into the clinic.

EQS-News: RATIONAL AG: Sales revenues up 14 percent after 9 months of 2023

Retrieved on: 
Tuesday, November 7, 2023
MDAX, Tax, Stainless steel, Food, Movement, Host, EBIT, Many, Growth, Social responsibility, Hand, CFO, UI, Investment, Video game, Tourism, Rationality

In the first nine months of this year, the company’s sales revenues rose by 14 percent to 833.1 million euros (2022: 731.9 million euros).

Key Points: 
  • In the first nine months of this year, the company’s sales revenues rose by 14 percent to 833.1 million euros (2022: 731.9 million euros).
  • Driven by good business with small and medium-sized customers in the United States, sales revenues in North America went up by 30 percent in the first nine months of 2023.
  • In the iCombi product group, sales revenues were up significantly, by 18 percent year-on-year, in the first nine months of 2023, at 745.8 million euros (2022: 634.0 million euros).
  • Cost of sales increased more slowly than sales revenues in the first nine months, up 8 percent to 362.1 million euros (2022: 334.6 million euros).

EQS-News: Evotec and Dewpoint Therapeutics enter strategic partnership in oncology

Retrieved on: 
Tuesday, November 7, 2023
MDAX, IND, Therapy, ISIN, Frankfurt Stock Exchange, INDIGO, EVO, Risk, Partnership, A.I, Hotel des Indes (The Hague), Dew point, IndiGo, Sales, Pharmaceutical industry, Evotec

The partnership brings together Dewpoint’s advanced oncology pipeline programmes discovered using its groundbreaking condensate biology and A.I.

Key Points: 
  • The partnership brings together Dewpoint’s advanced oncology pipeline programmes discovered using its groundbreaking condensate biology and A.I.
  • Dr Matthias Evers, Chief Business Officer of Evotec, commented: “We are excited to enter this strategic development partnership with Dewpoint.
  • By combining our complementary expertise, Evotec’s development platform will serve as the capital-efficient IND engine for this highly collaborative partnership.
  • We look forward to working closely together with their team to make Dewpoint’s groundbreaking innovations available to patients.”
    “Dewpoint’s strategic partnership with Evotec leverages the world-class speed of their development platform to accelerate our oncology assets into the clinic.

EQS-News: Evotec SE to announce results for the first nine months 2023 on 08 November 2023

Retrieved on: 
Tuesday, November 7, 2023
CET, MDAX, Frankfurt Stock Exchange, EVO, Webcast, PIN, ISIN, Cryptocurrency

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first nine months 2023 on Wednesday, 08 November 2023.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first nine months 2023 on Wednesday, 08 November 2023.
  • The Company is going to hold a conference call to discuss the results as well as provide an update on its performance.
  • Time: 2.00 pm CET (01.00 pm GMT, 08.00 am EST)
    To join the audio webcast and to access the presentation slides, please register via this link .
  • You will then receive a confirmation email with dedicated dial-in details such as telephone number, access code and PIN to access the call.

EQS-News: Aurubis AG: EcoVadis ranks Aurubis among the top one percent in its sector again

Retrieved on: 
Thursday, October 26, 2023
MDAX, CERES, Fruit, International Training Centre of the International Labour Organization, CSR, Sustainability, ESG, Frankfurt Stock Exchange, Science, Metal, Copper, Tin, Carbon, Electricity, Nickel, International Labour Organization, ILO, Global Compact, Hydrogen, Sustainable procurement, Environment, News, Selenium, Zinc, Lead, CO2, GRI, Natural Resources, ISO, Security (finance), Renewable energy, Mining, Ethics, Aurubis

The company improved its score in the ranking by five points, or about seven percent, compared to the previous year.

Key Points: 
  • The company improved its score in the ranking by five points, or about seven percent, compared to the previous year.
  • “The outstanding EcoVadis rating is evidence of our continuous efforts to improve in all aspects of sustainability.
  • Additionally, the rating agency classified Aurubis’ carbon management at the ‘leader’ level for the first time.
  • Their conditions are tied to the EcoVadis rating, and large parts of Aurubis’ factoring are linked to ESG as well.

EQS-News: ENCAVIS AG: Science Based Targets initiative (SBTi) confirms climate targets of ENCAVIS

Retrieved on: 
Thursday, October 26, 2023
MDAX, Science Based Targets initiative, Sustainability, Science, ISIN, Islamabad Wildlife Management Board, Carbon accounting, Sustainability reporting, Targets, Transport, CFO, Climate, Climate change, Renewable energy

Hamburg, 23 October 2023 - The independent Science Based Targets initiative (SBTi), following a thorough review, has officially confirmed that the climate targets of MDAX-listed wind and solar park operator Encavis AG (Prime Standard, ISIN: DE0006095003, stock xchange symbol: ECV) are in line with SBTi’s pathway of limiting global warming to 1.5°C.

Key Points: 
  • Hamburg, 23 October 2023 - The independent Science Based Targets initiative (SBTi), following a thorough review, has officially confirmed that the climate targets of MDAX-listed wind and solar park operator Encavis AG (Prime Standard, ISIN: DE0006095003, stock xchange symbol: ECV) are in line with SBTi’s pathway of limiting global warming to 1.5°C.
  • The goal is also to significantly decrease Scope 3 emissions, which ENCAVIS does not directly influence.
  • We are therefore delighted that the Science Based Targets initiative has officially confirmed our climate goals," commented Dr Christoph Husmann, Spokesperson of the Management Board and Chief Financial Officer (CFO) of Encavis AG.
  • ENCAVIS' climate targets are part of the Group's integrated sustainability strategy, which focuses on twelve key topics within four sustainability dimensions (economic, environmental, social and governance).

EQS-News: Encavis Asset Management AG expands existing wind farm at excellent location in Ireland for its Alternative Investment Fund

Retrieved on: 
Tuesday, October 17, 2023
Investment, ESG, Wind, Risk management, MDAX, Luxembourg, Bayerische Landesbank, MSCI, CO2, Electricity, SFDR, Growth, Maintenance, ISS, Primary energy, Rabigh 2 IPP, ISIN, United Nations Global Compact, UN, Krishna River Management Board, Security (finance), Renewable energy, Ticker

County Donegal on the west coast of Ireland, with average wind speeds exceeding eight metres per second, is an exceptionally windy and excellent location for generating clean wind energy.

Key Points: 
  • County Donegal on the west coast of Ireland, with average wind speeds exceeding eight metres per second, is an exceptionally windy and excellent location for generating clean wind energy.
  • Encavis Asset Management AG offers institutional investors tailor-made portfolios and fund solutions for investments in the growth market of Renewable Energies.
  • Encavis Asset Management AG is a wholly owned subsidiary of MDAX-listed Encavis AG (ISIN: DE0006095003, Prime Standard, Ticker symbol: ECV) and, as part of the Encavis Group, benefits from their many years of experience and broad industry network.
  • This corresponds to a total saving of around 0.8 million tonnes of CO2 per year stand-alone for the Encavis AG.

EQS-News: Krones AG: Inclusion of Krones shares in the SDAX

Retrieved on: 
Tuesday, October 17, 2023
Deutsch, Index, News, DAX, SDAX, SUSE, MDAX, Security (finance), Airline, Krones

Deutsche Börse AG has announced an unscheduled component change in the SDAX index.

Key Points: 
  • Deutsche Börse AG has announced an unscheduled component change in the SDAX index.
  • In connection with this change, Krones shares will be admitted to the SDAX as of 9 October 2023.
  • Following admission to the SDAX, the index comprising the 70 largest companies below MDAX, Krones returns to the index family of Deutsche Börse AG.
  • Consequently, Krones immediately implemented measures to regain a place in the Deutsche Börse ranking list and to become eligible for inclusion in the DAX index family again.

EQS-News: KION Group significantly improves earnings in Q3 2023: Outlook adjusted

Retrieved on: 
Tuesday, October 17, 2023
MDAX, ITS, Automation, KION, SCS, Prospectus, EBIT, Service, KION Group, Risk, Beauty salon, Video game, Online shopping

Due to the continuing positive effects of the measures initiated, the full-year outlook for adjusted EBIT in the ITS segment has been raised again.

Key Points: 
  • Due to the continuing positive effects of the measures initiated, the full-year outlook for adjusted EBIT in the ITS segment has been raised again.
  • KION GROUP AG will announce the final results for the third quarter of 2023 on October 26, 2023.
  • The KION Group is among the world’s leading suppliers of industrial trucks and supply chain solutions.
  • The KION Group is also one of the world’s leading providers of warehouse automation (as measured by revenue in 2021).

EQS-News: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'

Retrieved on: 
Tuesday, October 17, 2023
Partnership, NUS, National university, Drug development, MDAX, Polaris Partners, SCIENCE, Duke–NUS Medical School, Therapy, RESEARCH, National University of Singapore, FOR, Agency for Science, Technology and Research, Patient, Bayer, EVO, Frankfurt Stock Exchange, Academic Partnerships, SE, Growth, Evotec, Public sector, Duke University, University, LEAPS, POLARIS, Drug discovery, ISIN, Agency, AND, Pharmaceutical industry, Research, Science

“65LAB”, Evotec’s first academic BRIDGE in Asia, aims to advance drug discovery and the creation of new therapeutics companies in Singapore.

Key Points: 
  • “65LAB”, Evotec’s first academic BRIDGE in Asia, aims to advance drug discovery and the creation of new therapeutics companies in Singapore.
  • 65LAB was founded to establish a model of long-term partnership to foster future company growth and the development of Singapore’s biotech ecosystem.
  • 65LAB selects promising academic projects and invests up to US$ 1.5 m in each project over the course of 18-24 months.
  • The Board provides oversight and governance to 65LAB’s strategy and operations and includes Dr Wen Qi Ho, Therapeutics Lead, ClavystBio, Dr Christina Isacson, Partner, Lightstone Ventures, Dr Pei Sze Ng, Director, Leaps by Bayer, and Dr Kim Png, Principal, Polaris Partners.